Antoine B.
- Country
- France
- Department
- Oncology-Radiotherapy
Research Overview
- Evaluation of Therapeutic De-escalation in HER2-Positive Metastatic Breast Cancer Using Trastuzumab and Drug Combination in Patients with Controlled Disease
- Phase 3 Randomized Study of GLSI-100 (GP2 + Sargramostim) in HER2/neu Positive Breast Cancer with Residual Disease or High-Risk PCR Post-Trastuzumab Therapy
- Phase III Randomized Study of Cabazitaxel and Pelvic Radiotherapy in High-Risk Localized Prostate Cancer with Androgen Deprivation Therapy
Data & Insights
Has run more than one trial at 80 of 247 partner sites.
Specializations
Breast Cancer Specialization
Focused on innovative approaches in treating HER2-positive breast cancer, particularly exploring therapeutic interventions for patients with residual disease and those requiring maintenance treatment. Investigates advanced treatment strategies for both metastatic breast cancer and cases with high recurrence risk.
- HER2/neu peptide therapeutics
- Blood-based cancer monitoring
- Treatment de-escalation strategies
Head and Neck Cancer Treatment
Specializes in treating advanced squamous cell carcinoma of the head and neck region, with particular emphasis on combination therapies involving radiotherapy and targeted biological agents. Expertise extends across various anatomical sites including oral cavity, oropharynx, hypopharynx and larynx.
- Immunotherapy combinations
- Targeted biological therapy
- Radio-therapeutic approaches
Prostate Cancer Research
Concentrates on treating high-risk localized prostate cancer through integrated therapeutic approaches. Specializes in combining hormone therapy with radiation treatment and investigating novel therapeutic agents for improved patient outcomes.
- Neoadjuvant therapy
- Pelvic radiotherapy
- Hormone therapy integration
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.